-
Forward Look
Targeted Treatments for TotsNew law mandates that cancer drugs get tested in kids in clinical trials.
by Sharon Tregaskis
-
Forward Look
Medicare to Cover CAR-T Cell TherapyHigh cost may still limit access.
by Nancy Averett
-
Cancer Patient Advocates Find Strength in Numbers
Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.
by Marci A. Landsmann
-
Cancer and Credit
The financial burden of a cancer diagnosis can lower a patient's credit score.
by Shelly Rosenfeld
-
First Ladies of Africa Issue Call to Address Cancer Crisis
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
-
Get Involved
Stay CloseParticipants in Airbnb's Open Homes program help nonprofit organizations to provide temporary lodging for cancer patients.
by Katherine Malmo
-
Our Own Words
People with cancer and their loved ones find ways for their voices to be heard without filters.
by Bradley Jones
-
From the Editor-in-Chief
Value-Based Cancer Care: Paying for PerformanceThe Centers for Medicare & Medicaid Services implements incentive programs to reward quality care.
by William G. Nelson, MD, PhD
-
Forward Look
A New Use for Patient DataGregory Daniel on real-world evidence for cancer drug approvals.
by Sue Rochman
-
Policy Matters
FDA Seeks to Improve Access to Investigational Oncology DrugsProject Facilitate offers assistance to medical professionals who want investigational drugs for their cancer patients.
by Richard Pazdur, MD
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona